Social Media Perceptions Among Young Adults With Cancer - Online Experiment 2
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07928349. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Young adults with cancer experience more loneliness than their non-cancer peers or older cancer survivors. Positive psychology interventions have promise to increase social connectedness; however, evidence-based interventions should be tailored for young adults with cancer and designed for social media. The investigators conducted an online experiment with young adults with cancer (ages 22-39) to examine the most promising message types with personal stories to identify a suite of intervention messages that encourage positive, in-person social interactions with strangers and acquaintances (i.e., weak ties).
Study identification
- NCT ID
- NCT07928349
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Interventions
- Cancer Peer and Clinician Messages Behavioral
- Public Service Announcement Messages Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 22 Years to 39 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2025 (Actual)
- Primary completion
- Jan 15, 2026 (Actual)
- Completion
- Jan 15, 2026 (Actual)
- Last update posted
- Nov 10, 2026
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of North Carolina at Chapel Hill, Department of Radiation Oncology | Chapel Hill | North Carolina | 27599 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07928349, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2026 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.